You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
McKinsey
Express Scripts
Medtronic
Dow

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

OTREXUP PFS Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Otrexup Pfs patents expire, and when can generic versions of Otrexup Pfs launch?

Otrexup Pfs is a drug marketed by Antares Pharma Inc and is included in one NDA.

The generic ingredient in OTREXUP PFS is methotrexate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the methotrexate profile page.

Summary for OTREXUP PFS
Drug patent expirations by year for OTREXUP PFS
Recent Clinical Trials for OTREXUP PFS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Virginia Commonwealth UniversityPhase 1
University of Wisconsin, MadisonPhase 1
University of VirginiaPhase 1

See all OTREXUP PFS clinical trials

Pharmacology for OTREXUP PFS

US Patents and Regulatory Information for OTREXUP PFS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Antares Pharma Inc OTREXUP PFS methotrexate SOLUTION;SUBCUTANEOUS 204824-009 May 31, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
Antares Pharma Inc OTREXUP PFS methotrexate SOLUTION;SUBCUTANEOUS 204824-012 May 31, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
Antares Pharma Inc OTREXUP PFS methotrexate SOLUTION;SUBCUTANEOUS 204824-010 May 31, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
Antares Pharma Inc OTREXUP PFS methotrexate SOLUTION;SUBCUTANEOUS 204824-011 May 31, 2017 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
McKesson
AstraZeneca
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.